Akhilesh RaiAkhilesh Rai has completed Bachelor (B.Sc.) in Chemistry and Botany, Chemistry from Deen Dayal Upadhyay Gorakhpur University, Master (M.Sc.) in Biotechnology from Savitribai Phule Pune University and PhD in Biotechnology from Savitribai Phule Pune Unversity. After completion of his PhD, he moved to Nottingham Trent University, U.K. to pursue as a postdoctoral researcher on European Union FP7 project. He then moved to Universite Catholique Louvain as a postdoctoral researcher for 1 year. Then he joined as FCT postdoctoral fellow at the Centre for Neuroscience and Cell Biology, Coimbra, Portugal. In 2013, he joined as an assistant investigator at the Centre for Neuroscience and Cell Biology. In 2017, he was awarded the FCT Investigator grant and joined the Faculty of Medicine, University of Coimbra. Importantly, his team has been received the first prize at the first phase of the 7th Building Global Innovators (BGI-MIT Program) for the project related to the development of unique wound dressing for the treatment of the chronic wound, which led to the generation of the CureMat Technology. Our work related to antimicrobial nanoparticles have been recognized and I have been conferred the prestigious Bluepharma-University of Coimbra Innovation award (2015) for the project Bug-killer. He has published more than 24 papers in international peer-reviewed journals, 2 book chapters, 1 patent granted (2 patents submitted) with citations of more than 5000. He is also an active reviewer of many international journals related to nanotechnology, biodegradable NPs, antimicrobial materials, drug delivery, and antimicrobial surfaces. He was co-supervisor of 1 PhD student and supervisor of many master students for their theses. He is guest editor of the special issues of Nanomaterials and Antibiotics journals (MDPI publishers) and an editorial board member of the Journal of Applied Biopharmaceutics Pharmacokinetics. His research interests include the formulation of bioactive and peptide conjugated nanomaterials for regenerative medicine applications. His research group is involved in the development of light-sensitive nanoparticles for brain targeting and to understand the role of cytokines/chemokines on the integrity of the blood-brain barrier. His research group is also involved in the development of antimicrobial and bioactive coating on medical devices Read More Read Less